2023
DOI: 10.3390/jcdd10050220
|View full text |Cite
|
Sign up to set email alerts
|

Positron Emission Tomography in Heart Failure: From Pathophysiology to Clinical Application

Abstract: Imaging modalities are increasingly being used to evaluate the underlying pathophysiology of heart failure. Positron emission tomography (PET) is a non-invasive imaging technique that uses radioactive tracers to visualize and measure biological processes in vivo. PET imaging of the heart uses different radiopharmaceuticals to provide information on myocardial metabolism, perfusion, inflammation, fibrosis, and sympathetic nervous system activity, which are all important contributors to the development and progr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 143 publications
(187 reference statements)
0
1
0
Order By: Relevance
“…Positron emission tomography (PET) is a sensitive technique to study physiology, metabolism, and molecular pathways in living humans using labeled endogenous and natural exogenous compounds (Tersalvi et al, 2023;Toyama et al, 2021;Amoabeng et al, 2022). The ketone radiotracer 11 C-acetoacetate ( 11 C-AcAc) was developed to assess brain ketone metabolism in conditions such as mild cognitive impairment and Alzheimer's disease (Croteau et al, 2018), which are characterized by regional brain glucose hypometabolism but with preserved brain ketone metabolism (Cunnane et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…Positron emission tomography (PET) is a sensitive technique to study physiology, metabolism, and molecular pathways in living humans using labeled endogenous and natural exogenous compounds (Tersalvi et al, 2023;Toyama et al, 2021;Amoabeng et al, 2022). The ketone radiotracer 11 C-acetoacetate ( 11 C-AcAc) was developed to assess brain ketone metabolism in conditions such as mild cognitive impairment and Alzheimer's disease (Croteau et al, 2018), which are characterized by regional brain glucose hypometabolism but with preserved brain ketone metabolism (Cunnane et al, 2020).…”
Section: Introductionmentioning
confidence: 99%